Colin Rusch, Oppenheimer senior research analyst, joins 'Squawk Box' to discuss Tesla's stock performance, the company's ...
Tesla's ( TSLA) beat-up stock has found support on the charts, for now. After a brutal stretch this month that brought the ...
Tesla (NASDAQ:TSLA) shares rose 2.5% today, but the stock remains down ~17% year-to-date, suggesting the post-election ...
Oppenheimer adjusted its outlook on Albemarle Corporation (NYSE:ALB), a global developer of lithium and other chemical solutions. The firm's analyst, Colin W. Rusch, reduced the price target to $123 ...
One Wall Street analyst believes Tesla CEO Elon Musk’s gambit for OpenAI is a distraction for the company at a very important time.
3don MSN
Oppenheimer weighs in on Tesla's future amid rising AI competition and Musk's distractions. Learn about demand trends and ...
Elon Musk’s “public life risks alienating consumers and employees” at Tesla, remarked Oppenheimer analysts in a Tuesday ...
A sea of people clad in red pushed up against the barricades on Canal Street, waiting for a glimpse of their team leaving the ...
Discover Aspen Aerogels' Q4 2024 earnings highlights, including 90% revenue growth, profitability milestones, and key market strategies for 2025.
Bus ridership has increased across Madison following the launch of the city’s Bus Rapid Transit system, Metro Transit said this week.
Jay Peak's 6th annual Real To Steel event blends freeride and slopestyle, testing the adaptability of competitors.
4d
News Medical on MSNStem cell shots: Unveiling a safer way to treat inflammatory eye diseasesGraft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results